Boston – DPS Group, a privately-owned global consulting, engineering, and construction management company serving high-tech industries around the world, celebrated its 10th anniversary in the U.S. this past year.
Founded in 1974 in Dublin, Ireland to service the country’s burgeoning pharmaceutical sector, DPS Group opened its first office in the U.S. in 2011 with a staff of less than 10 based in Framingham, Mass. The company has since grown its U.S. presence to over 900 employees across eight offices all across the U.S.
“Our approach has always been to take care of our clients and serve their needs first,” said Aidan O’Dwyer, president of U.S. project operations. “We are excited about the future and look forward to partnering with our clients to bring cutting-edge discoveries to market.”
Within the life sciences sector there has been a significant focus in recent years on designing facilities for novel therapies, including mRNA, microbiome, oligonucleotide, cell, and gene therapy, requiring DPS to respond in terms of facility design, construction, regulatory compliance, and licensing requirements.
“Covid-19 has been a really tough period for everyone, and DPS is fortunate to be able to play a small part in the fight against the pandemic,” said O’Dwyer. “In the life sciences sector, DPS has supported 16 COVID-related projects ranging from vaccines and therapeutics to diagnostic tests, while in the semi-conductor sector we executed numerous projects in response to the global shortage of microchips.”
Representatives of the firm say DPS has a commitment to its clients and deep connections to the communities they serve. Through scholarships, donation drives, financial contributions, sponsorships, and the time and effort of employees, each DPS office immerses itself in actions that support their localities.
“We are absolutely thrilled to celebrate 10 years in the United States,” said O’Dwyer. “Over the past decade we’ve invested heavily in growing our U.S. presence. That investment has allowed us deliver world class service for our clients and has created a culture of professional satisfaction and career fulfillment for our staff.”
O’Dwyer continued, “We devote a huge amount of time and effort into finding and recruiting the best people to our team and providing professional development opportunities to our employees. We partner closely with colleges and universities near our offices, providing internship opportunities and scholarships to develop the next generation of talent. Once someone joins our team we invest heavily in their professional development, always conscious of preparing them to advance to the next step of their career.”
DPS-designed facilities have been recognized by the International Society of Pharmaceutical Engineers (ISPE) with two prestigious Facility of the Year Awards (FOYA). In 2019, Moderna’s new clinical development manufacturing facility in Norwood, Mass. was the category winner for Facility of the Future and ElevateBio’s BaseCamp project in Waltham, Mass. was the 2021 category winner for Operational Excellence.